Sort   by:  
 Page size 
UnknownStructural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases.
Not available
S-EPMC3716117 | biostudies-literature
UnknownEfficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).
Not available
S-EPMC10844204 | biostudies-literature
UnknownKinetics of avibactam inhibition against Class A, C, and D β-lactamases.
Not available
S-EPMC3784710 | biostudies-literature
UnknownSingle cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
Not available
S-EPMC8524723 | biostudies-literature
UnknownBlood-based proteomic profiling identifies OSMR as a novel biomarker of AML outcomes.
Not available
S-EPMC12226760 | biostudies-literature
UnknownA cosmic-ray loaded nascent outflow driven by a massive star cluster.
Not available
S-EPMC12690131 | biostudies-literature
UnknownSingle-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy.
Not available
S-EPMC10916538 | biostudies-literature
UnknownSAR and Structural Analysis of Siderophore-Conjugated Monocarbam Inhibitors of Pseudomonas aeruginosa PBP3.
Not available
S-EPMC4434466 | biostudies-literature
UnknownNivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study.
Not available
S-EPMC7969746 | biostudies-literature
UnknownConsensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL.
Not available
S-EPMC11993837 | biostudies-literature
Sort   by:  
 Page size